Allison Portnoy
Profiles

Allison Portnoy, ScD

Assistant Professor, Global Health - Boston University School of Public Health

(617) 358-0041
aportnoy@bu.edu
Crosstown Center
View Full Profile at BUMC

Biography

Dr. Allison Portnoy is an assistant professor of global health focused on vaccine decision science and policy. Her research includes economic evaluation and public health policy, simulation modeling, health equity, and the impact of vaccination on population health and economic outcomes. She is particularly interested in broadening the value of vaccination in high-burden settings. Her ongoing work spans multiple diseases areas, including human papillomavirus (HPV), measles, and tuberculosis (TB).

Dr. Portnoy received a Doctor of Science from the Department of Global Health and Population and completed a postdoctoral fellowship at the Center for Health Decision Science, both at the Harvard T.H. Chan School of Public Health. Her previous education includes an MSPH in Health Policy & Management from the Johns Hopkins Bloomberg School of Public Health and a BA in International Relations from Stanford University. She previously worked as a health economist at the International Vaccine Access Center at Johns Hopkins, and conducted research projects with the World Health Organization, Agency for Healthcare Research and Quality, and the University of Washington in Seattle.

Education

  • Harvard School of Public Health, ScD Field of Study: Global Health

Websites

Publications

  • Published on 12/18/2024

    Moghtaderi A, Callaghan T, Luo Q, Motta M, Tan TQ, Hillard L, Dor A, Portnoy A, Winter A, Black B. Evidence on trends in uptake of childhood vaccines and association with COVID-19 vaccination rates. Vaccine. 2025 Jan 25; 45:126631. PMID: 39700909.

     Read At: PubMed
  • Published on 12/1/2024

    Shankar M, Hartner AM, Arnold CRK, Gayawan E, Kang H, Kim JH, Gilani GN, Cori A, Fu H, Jit M, Muloiwa R, Portnoy A, Trotter C, Gaythorpe KAM. How mathematical modelling can inform outbreak response vaccination. BMC Infect Dis. 2024 Dec 01; 24(1):1371. PMID: 39617902.

     Read At: PubMed
  • Published on 11/12/2024

    Lambach P, Silal S, Sbarra AN, Koh M, Aggarwal R, Farooqui HH, Flasche S, Hogan AB, Kim SY, Leung K, Moss WJ, Munywoki PK, Portnoy A, Sheel M, Wang XY. Report from the World Health Organization's immunization and vaccines-related implementation research advisory committee (IVIR-AC) meeting, virtual gathering, 10-13 September 2024. Vaccine. 2025 Jan 01; 43(Pt 2):126519. PMID: 39536476.

     Read At: PubMed
  • Published on 11/1/2024

    Burger EA, Laprise JF, Portnoy A, Spencer JC, Sy S, Regan MC, Bénard É, Drolet M, Brisson M, Kim JJ. Population-level health impact of hypothetical waning 1-dose human papillomavirus vaccination and 2-dose mitigation strategies in a high cervical cancer burden setting. J Natl Cancer Inst Monogr. 2024 Nov 01; 2024(67):379-386. PMID: 39529530.

     Read At: PubMed
  • Published on 9/14/2024

    Lambach P, Silal S, Sbarra AN, Crowcroft NS, Frey K, Ferrari M, Vynnycky E, Metcalf CJE, Winter AK, Zimmerman L, Koh M, Sheel M, Kim SY, Munywoki PK, Portnoy A, Aggarwal R, Farooqui HH, Flasche S, Hogan AB, Leung K, Moss WJ, Wang XY. Report from the World Health Organization's immunization and vaccines-related implementation research advisory committee (IVIR-AC) ad hoc meeting, 28 June - 1 July 2024. Vaccine. 2024 Dec 02; 42(26):126307. PMID: 39276622.

     Read At: PubMed
  • Published on 9/13/2024

    Gaythorpe KAM, Li X, Clapham H, Dansereau E, Fitzjohn R, Hinsley W, Hogan D, Jit M, Mengistu T, Perkins TA, Portnoy A, Vynnycky E, Woodruff K, Ferguson NM, Trotter CL. Estimating the impact of vaccination: lessons learned in the first phase of the Vaccine Impact Modelling Consortium. Gates Open Res. 2024; 8:97. PMID: 39398325.

     Read At: PubMed
  • Published on 7/11/2024

    Lambach P, Silal S, Sbarra AN, Koh M, Aggarwal R, Farooqui HH, Flasche S, Hogan AB, Kim SY, Leung K, Moss WJ, Munywoki PK, Portnoy A, Sheel M, Wang XY. Corrigendum to "Report from the World Health Organization's immunization and vaccines-related implementation research advisory committee (IVIR-AC) meeting, virtual gathering, 26 February-1 March 2024" [Vaccine 42(15) (2024) 3379-3383]. Vaccine. 2024 Oct 03; 42(23):126102. PMID: 38991915.

     Read At: PubMed
  • Published on 6/3/2024

    Clarke-Deelder E, Suharlim C, Chatterjee S, Portnoy A, Brenzel L, Ray A, Cohen JL, Menzies NA, Resch SC. Health impact and cost-effectiveness of expanding routine immunization coverage in India through Intensified Mission Indradhanush. Health Policy Plan. 2024 Jun 03; 39(6):583-592. PMID: 38590052.

     Read At: PubMed
  • Published on 5/16/2024

    Clark RA, Portnoy A, Weerasuriya CK, Sumner T, Bakker R, Harris RC, Rade K, Mattoo SK, Tumu D, Menzies NA, White RG. Estimating the potential health and economic impacts of new tuberculosis vaccines under varying delivery strategies in Delhi and Gujarat, India: a modelling study. Lancet Reg Health Southeast Asia. 2024 Dec; 31:100424. PMID: 39957772.

     Read At: PubMed
  • Published on 5/3/2024

    Lambach P, Silal S, Sbarra AN, Koh M, Aggarwal R, Farooqui HH, Flasche S, Hogan AB, Kim SY, Leung K, Moss WJ, Munywoki PK, Portnoy A, Sheel M, Wang XY. Report from the World Health Organization's immunization and vaccines-related implementation research advisory committee (IVIR-AC) meeting, virtual gathering, 26 February-1 March 2024. Vaccine. 2024 May 31; 42(15):3379-3383. PMID: 38704250.

     Read At: PubMed

View 53 more publications:View Full Profile at BUMC

News & In the Media

View all profiles